News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.
stomach cancer research studies

BeiGene Initiates Global Phase 3 Trial of PARP Inhibitor Pamiparib in Patients with Advanced Gastric Cancer

A global Phase 3 trial is comparing the efficacy and safety of pamiparib to placebo as maintenance therapy in advanced gastric cancer patients who have responded to first-line platinum-based chemotherapy.

Read Source
X